1.03
Clearmind Medicine Inc Borsa (CMND) Ultime notizie
Clearmind Medicine Inc. Stock Analysis and ForecastRapidly expanding wealth - PrintWeekIndia
Is Clearmind Medicine Inc. a good long term investmentHigh-performance investment picks - PrintWeekIndia
Why TRUMP(maga) Will ExplodeMarket Ready Callouts - Newser
What drives Clearmind Medicine Inc. stock priceExceptional trading results - Autocar Professional
What analysts say about Clearmind Medicine Inc. stockPowerful growth strategies - Autocar Professional
Clearmind Medicine Inc Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder - MarketScreener
Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder - The Manila Times
Clearmind advances AUD treatment with new trial site in Tel Aviv - Investing.com
Clearmind Medicine Inc. Announces Successful Site Initiation for Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center - Nasdaq
Clearmind Medicine Surges 18.99%: What's Fueling This Volatile Biotech Rally? - AInvest
How Clearmind Medicine Inc. stock reacts to Fed policy changesFree Access to Community with 300% Return - beatles.ru
What makes Clearmind Medicine Inc. stock price move sharplySmart Money Trade Setups - beatles.ru
Clearmind Expands its Clinical Trial for Alcohol Use, New Site Activated and Additional Participant Enrolled - MarketScreener
How Clearmind Medicine Inc. stock performs during market volatilityFree High-Accuracy Stock Picks - Newser
Why Clearmind Medicine Inc. stock attracts strong analyst attentionTriple Return With Stability - Newser
Clearmind Expands Its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled - MarketScreener
Clearmind expands phase I/IIa trial for alcohol use disorder treatment By Investing.com - Investing.com South Africa
Clearmind expands phase I/IIa trial for alcohol use disorder treatment - Investing.com India
Clearmind Medicine Inc. Expands Phase I/IIa Clinical Trial for CMND-100 to Johns Hopkins University to Address Alcohol Use Disorder - Nasdaq
Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled - The Manila Times
Clearmind Medicine (NASDAQ:CMND) Stock Price Up 4.5% – Here’s Why - Defense World
Alcohol Use Disorder Market Report 2025-2035 Featuring Clearmind Medicine, Purdue Pharma, Psyence Biomedical, Eli Lilly and Co, Tempero Bio,, Nxera Pharma, Novo Nordisk, Adial, Alkermes, Lundbeck - Yahoo Finance
Clearmind Medicine Soars 32.89% on Clinical Trial Approval - AInvest
CMND’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com
Clearmind Gains IRB Approval At TASMC For Alcohol Use Disorder Drug Trial - Nasdaq
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):